Editors’ Picks: January 2024 Highlights from the AACR Journals
January’s selections include disparities in genetic testing, updates from a breast cancer clinical trial, and more.
January’s selections include disparities in genetic testing, updates from a breast cancer clinical trial, and more.
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
Radiotherapy is a mainstay of cancer treatment. In recent years, improved technology has allowed many cancer patients to receive...
The editors of AACR's journals highlight studies from May, including machine learning, savings from quitting smoking, and more.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one...
The term “hackathon” may conjure up images of beanie-wearing coders working in dark basements, trying to build a new...
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
This spring, in the inaugural year of the American Association for Cancer Research (AACR) Global-Scholar-In-Training Awards (GSITA) program, 15...
A session at the AACR Annual Meeting 2024 offered advice on better ways to communicate science to the public....
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
Insights from the AACR Cancer Disparities Progress Report 2024.
Highlights from a roundtable featuring cancer survivors and researchers discussing cancer disparities and persistent health inequities.
The era of targeted cancer therapy has fundamentally transformed the way several cancers are treated and has provided new...
“What will you do Monday morning?” was the question posed by the final session on the final full day...
In the fall issue, Cancer Today had the honor of highlighting two women whose cancer diagnoses led them to...
The AACR Annual Meeting 2023 kicks off Friday, April 14, with thousands of cancer researchers from around the world...
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
We asked experts in cancer precision medicine, immunotherapy, and prevention what breakthroughs we might expect to see in 2016...
A special issue of Cancer Discovery illustrates the vast landscape of research being explored within the AACR community.
Researchers are exploring new options for kidney cancer treatments.
The American Association for Cancer Research (AACR) often participates in cancer-related Twitter chats, and we welcome Twitter novices and...
Guest Post by Angela Alexander, PhD Member of the AACR's Associate Member Council Communications Committee
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
Researchers at the AACR Annual Meeting 2024 examined new treatment options for brain tumors.
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.